Trial Profile
Efficacy, safety and tolerability of perindopril/Indapamide (10 mg/2.5 mg) in patients with arterial hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2015
Price :
$35
*
At a glance
- Drugs Perindopril/indapamide (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2015 New trial record
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.